Close Menu

NEW YORK – Organoids grown from tumor biopsies may to be able to help guide treatment choices for colorectal cancer patients. 

While chemotherapy is a standard treatment approach for colorectal cancer patients, it comes with side effects, and not all patients actually respond to it. Being able to better guide that treatment choice would enable a precision oncology approach in which patients receive a treatment regime they are more likely to respond to.

Get the full story with
Premium Access

Only $95 for the
first 90 days*

Premium Access gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try Premium Access now.

You may already have institutional access!

Check if I qualify.

Already a Precision Oncology News or 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.